BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13771292)

  • 1. Increased dihydrofolate reductase activity as a possible basis of drug resistance in leukaemia.
    MISRA DK; HUMPHREYS SR; FRIEDKIN M; GOLDIN A; CRAWFORD EJ
    Nature; 1961 Jan; 189():39-42. PubMed ID: 13771292
    [No Abstract]   [Full Text] [Related]  

  • 2. The association of increased dihydrofolate reductase with amethopterin resistance in mouse leukemia.
    FRIEDKIN M; CRAWFORD E; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Jun; 22():600-6. PubMed ID: 13895219
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cells.
    FISCHER GA
    Biochem Pharmacol; 1961 Jul; 7():75-7. PubMed ID: 13699838
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of folic acid reductase to amethopterin resistance in cultured mammalian cells.
    HAKALA MT; ZAKRZEWSKI SF; NICHOL CA
    J Biol Chem; 1961 Mar; 236():952-8. PubMed ID: 13710631
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
    Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin.
    Albrecht AM; Biedler JL; Hutchison DJ
    Cancer Res; 1972 Jul; 32(7):1539-46. PubMed ID: 4402276
    [No Abstract]   [Full Text] [Related]  

  • 8. A DIRECT ASSAY FOR DIHYDROFOLATE REDUCTASE IN HUMAN LEUKOCYTES.
    MISRA DK
    Blood; 1964 May; 23():572-80. PubMed ID: 14142499
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterisation of a new transposon-mediated trimethoprim-resistant dihydrofolate reductase.
    Young HK; Amyes SG
    Biochem Pharmacol; 1985 Dec; 34(24):4334-7. PubMed ID: 3000384
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological activity and intracellular metabolism of ZD1694 in human leukemia cell lines with different resistance mechanisms to antifolate drugs.
    Takemura Y; Kobayashi H; Miyachi H; Gibson W; Kimbell R; Jackman AL
    Jpn J Cancer Res; 1996 Jul; 87(7):773-80. PubMed ID: 8698629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug response, dihydrofolate reductase, and cytogenetics of amethopterin-resistant Chinese hamster cells in vitro.
    Biedler JL; Albrecht AM; Hutchison DJ; Spengler BA
    Cancer Res; 1972 Jan; 32(1):153-61. PubMed ID: 5007683
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
    Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
    Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
    Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
    Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR
    Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of dihydrofolate reductase by inhibitors in vivo and in vitro.
    Hillcoat BL; Marshall L; Gauldie J; Hiebert M
    Ann N Y Acad Sci; 1971 Nov; 186():187-208. PubMed ID: 4332034
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of dihydrofolate reductase.
    Burchall JJ
    Postgrad Med J; 1969 Nov; 45():Suppl:29-32. PubMed ID: 5361306
    [No Abstract]   [Full Text] [Related]  

  • 18. Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance.
    Anderson AC
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Mar; 61(Pt 3):258-62. PubMed ID: 16511011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of dihydrofolate reductase in studies of mixed populations of sensitive and resistant leukemic cells.
    FRIEDKIN M; GOLDIN A
    Cancer Res; 1962 Jun; 22():607-16. PubMed ID: 13895220
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the effect of antifolics in mouse leukemia.
    Motycka K
    Natl Cancer Inst Monogr; 1971 Dec; 34():167-77. PubMed ID: 4110901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.